 SEATTLE, March 08, 2022 GLOBE NEWSWIRE -- Sana Biotechnology, Inc. NASDAQ: SANA, a company focused on creating and delivering engineered cells as medicines, today announced that preclinical data from its hypoimmune T cell program will be presented at the 2022 American Association for Cancer Research AACR Annual Meeting taking place April 8-13, 2022 in New Orleans, LA. 